Literature DB >> 25371952

Conservative management of degenerative disorders of the spine.

M Isgro, R Buraschi, C Barbieri, E Baruzzi, G Imperio, F Noro, J H Villafañe, S Negrini.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25371952

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN： 0390-5616            Impact factor:   2.279


× No keyword cloud information.
  5 in total

1.  Spinal deformity and malocclusion association is not supported by high-quality studies: results from a systematic review of the literature.

Authors:  Francesco Langella; Federico Fusini; Gregorio Rossi; Jorge Hugo Villafañe; Nicola Migliaccio; Sabrina Donzelli; Pedro Berjano
Journal:  Eur Spine J       Date:  2019-01-23       Impact factor: 3.134

2.  Spinopelvic balance and body image perception in Parkinson's disease: analysis of correlation.

Authors:  Luciano Bissolotti; Federica Isacco-Grassi; Claudio Orizio; Massimiliano Gobbo; Pedro Berjano; Jorge Hugo Villafañe; Stefano Negrini
Journal:  Eur Spine J       Date:  2015-10-06       Impact factor: 3.134

3.  Global Postural Reeducation in patients with chronic nonspecific neck pain: cross-over analysis of a randomized controlled trial.

Authors:  Paolo Pillastrini; Federico Banchelli; Andrew Guccione; Emanuele Di Ciaccio; Francesco Saverio Violante; Monia Brugnettini; Carla Vanti
Journal:  Med Lav       Date:  2018-02-01       Impact factor: 1.275

4.  The accuracy of pain drawing in identifying psychological distress in low back pain-systematic review and meta-analysis of diagnostic studies.

Authors:  Lucia Bertozzi; Anna Rosso; Antonio Romeo; Jorge Hugo Villafañe; Andrew A Guccione; Paolo Pillastrini; Carla Vanti
Journal:  J Phys Ther Sci       Date:  2015-10-30

5.  Trunk and craniofacial asymmetry are not associated in the general population: a cross-sectional study of 1029 adolescents.

Authors:  Chiara Arienti; Jorge Hugo Villafañe; Sabrina Donzelli; Fabio Zaina; Riccardo Buraschi; Stefano Negrini
Journal:  Eur J Med Res       Date:  2017-09-29       Impact factor: 2.175
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.